Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...

On World Cancer Day, Servier reaffirms its commitment to the fight against cancer by focusing on oncology as a central part of its Research & ...

As one of the world’s foremost medical universities, KI accounts for the single largest share of all academic medical research conducted in Sweden. KI also offers the country’s broadest range of ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

S-95035 is under clinical development by Les Laboratoires Servier and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

Servier has also filed vorasidenib in other ... performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the At the Veeva Commercial ...

S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition ...

Medical underwriting refers to how a life, disability, or health insurer uses an applicant's medical history to determine eligibility, coverage offers, and pricing. For medically underwritten coverage ...

Major medical health insurance is a type of health insurance that covers the expenses associated with serious illness or hospitalization. When choosing a health plan, it's important to understand what ...

Servier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name Cosyrel, which is approved as a substitution therapy for the treatment of ...

Servier is extending its pact with Google Cloud as the French biopharma points to 60 examples of how generative artificial intelligence could improve its drug development processes. The two ...